Cambridge Investment Research Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-10,000
| Closed | -$27K | – | 3191 |
|
2021
Q3 | $27K | Hold |
10,000
| – | – | ﹤0.01% | 3048 |
|
2021
Q2 | $28K | Hold |
10,000
| – | – | ﹤0.01% | 3052 |
|
2021
Q1 | $30K | Hold |
10,000
| – | – | ﹤0.01% | 2830 |
|
2020
Q4 | $30K | Hold |
10,000
| – | – | ﹤0.01% | 2671 |
|
2020
Q3 | $32K | Hold |
10,000
| – | – | ﹤0.01% | 2473 |
|
2020
Q2 | $33K | Hold |
10,000
| – | – | ﹤0.01% | 2396 |
|
2020
Q1 | $36K | Hold |
10,000
| – | – | ﹤0.01% | 2209 |
|
2019
Q4 | $52K | Hold |
10,000
| – | – | ﹤0.01% | 2353 |
|
2019
Q3 | $59K | Hold |
10,000
| – | – | ﹤0.01% | 2266 |
|
2019
Q2 | $64K | Hold |
10,000
| – | – | ﹤0.01% | 2134 |
|
2019
Q1 | $58K | Hold |
10,000
| – | – | ﹤0.01% | 2222 |
|
2018
Q4 | $60K | Hold |
10,000
| – | – | ﹤0.01% | 2077 |
|
2018
Q3 | $57K | Hold |
10,000
| – | – | ﹤0.01% | 2181 |
|
2018
Q2 | $61K | Hold |
10,000
| – | – | ﹤0.01% | 2148 |
|
2018
Q1 | $67K | Hold |
10,000
| – | – | ﹤0.01% | 2083 |
|
2017
Q4 | $74K | Hold |
10,000
| – | – | ﹤0.01% | 2047 |
|
2017
Q3 | $71K | Hold |
10,000
| – | – | ﹤0.01% | 1941 |
|
2017
Q2 | $70K | Hold |
10,000
| – | – | ﹤0.01% | 1870 |
|
2017
Q1 | $69K | Hold |
10,000
| – | – | ﹤0.01% | 1717 |
|
2016
Q4 | $55K | Hold |
10,000
| – | – | ﹤0.01% | 1621 |
|
2016
Q3 | $50K | Hold |
10,000
| – | – | ﹤0.01% | 1700 |
|
2016
Q2 | $45K | Hold |
10,000
| – | – | ﹤0.01% | 1522 |
|
2016
Q1 | $45K | Hold |
10,000
| – | – | ﹤0.01% | 1558 |
|
2015
Q4 | $53K | Hold |
10,000
| – | – | ﹤0.01% | 1529 |
|
2015
Q3 | $58K | Hold |
10,000
| – | – | ﹤0.01% | 1385 |
|
2015
Q2 | $72K | Hold |
10,000
| – | – | ﹤0.01% | 1386 |
|
2015
Q1 | $67K | Hold |
10,000
| – | – | ﹤0.01% | 1362 |
|
2014
Q4 | $60K | Hold |
10,000
| – | – | ﹤0.01% | 1324 |
|
2014
Q3 | $49K | Hold |
10,000
| – | – | ﹤0.01% | 1426 |
|
2014
Q2 | $45K | Buy |
+10,000
| New | +$45K | ﹤0.01% | 1312 |
|